ESG Report

Overview

The report is Aquestive Therapeutics' first Sustainability Report, covering ESG efforts and performance for Fiscal Year 2022. The company highlights LED upgrades that reduce power usage by 84,000 kWh and 43,000 kWh, as well as lower air and road travel versus 2019. It also describes patient-access initiatives including free medicines for qualifying uninsured patients, a $0 co-pay program, discounts, and prior-authorization support.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services